Standard

Production of peptides as generic drugs: a patent landscape of octreotide. / Sabatino, Giuseppina; Guryanov, Ivan; Rombecchi, Andrea; Zanon, Jacopo; Ricci, Antonio; Cabri, Walter; Papini, Anna Maria; Rovero, Paolo.

в: Expert Opinion on Therapeutic Patents, Том 26, № 4, 2016, стр. 485-495.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Sabatino, G, Guryanov, I, Rombecchi, A, Zanon, J, Ricci, A, Cabri, W, Papini, AM & Rovero, P 2016, 'Production of peptides as generic drugs: a patent landscape of octreotide', Expert Opinion on Therapeutic Patents, Том. 26, № 4, стр. 485-495. https://doi.org/10.1517/13543776.2016.1158810, https://doi.org/10.1517/13543776.2016.1158810

APA

Sabatino, G., Guryanov, I., Rombecchi, A., Zanon, J., Ricci, A., Cabri, W., Papini, A. M., & Rovero, P. (2016). Production of peptides as generic drugs: a patent landscape of octreotide. Expert Opinion on Therapeutic Patents, 26(4), 485-495. https://doi.org/10.1517/13543776.2016.1158810, https://doi.org/10.1517/13543776.2016.1158810

Vancouver

Sabatino G, Guryanov I, Rombecchi A, Zanon J, Ricci A, Cabri W и пр. Production of peptides as generic drugs: a patent landscape of octreotide. Expert Opinion on Therapeutic Patents. 2016;26(4):485-495. https://doi.org/10.1517/13543776.2016.1158810, https://doi.org/10.1517/13543776.2016.1158810

Author

Sabatino, Giuseppina ; Guryanov, Ivan ; Rombecchi, Andrea ; Zanon, Jacopo ; Ricci, Antonio ; Cabri, Walter ; Papini, Anna Maria ; Rovero, Paolo. / Production of peptides as generic drugs: a patent landscape of octreotide. в: Expert Opinion on Therapeutic Patents. 2016 ; Том 26, № 4. стр. 485-495.

BibTeX

@article{13e981d7bacd400e973325122c267667,
title = "Production of peptides as generic drugs: a patent landscape of octreotide",
abstract = "Introduction: New low-cost strategies and enhancement of the already described methods to manufacture peptide molecules on an industrial scale are highly requested, particularly for peptides such as octreotide, which, along with goserelin and leuprolide, dominate the global peptide market. A number of patents related to the production of octreotide can be found, concerning both solution and solid-phase synthesis. Thus, there is a need to revise the existing synthetic approaches in order to organize them in a more comprehensible way.Area covered: The octreotide patent landscape could help improvement of the methods for manufacturing of octreotide in industrial scale, leading to the appearance of innovative approaches.Expert opinion: The pharmaceutical value of octreotide can be seen from its high market percentage among other peptide drugs. The complex chemical structure of octreotide represents the main challenge for its industrial production. Two synthetic steps are crucial in the preparation of octreotide:",
author = "Giuseppina Sabatino and Ivan Guryanov and Andrea Rombecchi and Jacopo Zanon and Antonio Ricci and Walter Cabri and Papini, {Anna Maria} and Paolo Rovero",
year = "2016",
doi = "10.1517/13543776.2016.1158810",
language = "English",
volume = "26",
pages = "485--495",
journal = "Expert Opinion on Therapeutic Patents",
issn = "1354-3776",
publisher = "Taylor & Francis",
number = "4",

}

RIS

TY - JOUR

T1 - Production of peptides as generic drugs: a patent landscape of octreotide

AU - Sabatino, Giuseppina

AU - Guryanov, Ivan

AU - Rombecchi, Andrea

AU - Zanon, Jacopo

AU - Ricci, Antonio

AU - Cabri, Walter

AU - Papini, Anna Maria

AU - Rovero, Paolo

PY - 2016

Y1 - 2016

N2 - Introduction: New low-cost strategies and enhancement of the already described methods to manufacture peptide molecules on an industrial scale are highly requested, particularly for peptides such as octreotide, which, along with goserelin and leuprolide, dominate the global peptide market. A number of patents related to the production of octreotide can be found, concerning both solution and solid-phase synthesis. Thus, there is a need to revise the existing synthetic approaches in order to organize them in a more comprehensible way.Area covered: The octreotide patent landscape could help improvement of the methods for manufacturing of octreotide in industrial scale, leading to the appearance of innovative approaches.Expert opinion: The pharmaceutical value of octreotide can be seen from its high market percentage among other peptide drugs. The complex chemical structure of octreotide represents the main challenge for its industrial production. Two synthetic steps are crucial in the preparation of octreotide:

AB - Introduction: New low-cost strategies and enhancement of the already described methods to manufacture peptide molecules on an industrial scale are highly requested, particularly for peptides such as octreotide, which, along with goserelin and leuprolide, dominate the global peptide market. A number of patents related to the production of octreotide can be found, concerning both solution and solid-phase synthesis. Thus, there is a need to revise the existing synthetic approaches in order to organize them in a more comprehensible way.Area covered: The octreotide patent landscape could help improvement of the methods for manufacturing of octreotide in industrial scale, leading to the appearance of innovative approaches.Expert opinion: The pharmaceutical value of octreotide can be seen from its high market percentage among other peptide drugs. The complex chemical structure of octreotide represents the main challenge for its industrial production. Two synthetic steps are crucial in the preparation of octreotide:

U2 - 10.1517/13543776.2016.1158810

DO - 10.1517/13543776.2016.1158810

M3 - Article

VL - 26

SP - 485

EP - 495

JO - Expert Opinion on Therapeutic Patents

JF - Expert Opinion on Therapeutic Patents

SN - 1354-3776

IS - 4

ER -

ID: 7927155